Global Pharmaceutical News

Germany to use controversial biomass amid energy crisis

UK MHRA approves AbbVie’s migraine prevention drug Aquipta

European PFAS ban would burden drug companies and packagers

German government mulls limiting biofuel production

Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs

Avian influenza cases seen in mammals pose low risk for humans, health agencies say

EU chemical and pharmaceutical trade: robust growth

Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of

Importance of data analysis in healthcare

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

A Degree in Health Science Could Be Just What the Doctor Ordered

FDA Puts Clinical Hold on Hemogenyx’s CAR-T AML Therapy

Novavax Amends COVID-19 Contract with Canada, Snags $350M for Unused Shots

BrainStorm Builds NurOwn’s Case in ALS with Biomarker Data

CRISPR on the Cusp: The Promise and the Pain Points

BMS’ Sotyktu gets NICE green light for NHS use

King’s College London and Pioneer Group in incubator link-up

J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal

BeiGene Ups ADC Investment with $1.3B DualityBio Licensing Deal

Edinburgh researchers and LifeArc to boost MND treatment processes

TME Pharma reveals positive NOX-A12 data

DigitalHealth.London’s Accelerator programme selects Aide

University of Oxford and PrecisionLife reach data agreement

Genfit and Ipsen announce elafibranor results